Evaluation and Management of Fever with Hyperferritinemic Syndrome
In a patient presenting with fever and hyperferritinemia, immediately measure serum ferritin level and calculate transferrin saturation (TSAT) to distinguish life-threatening hyperferritinemic syndromes from other causes, then urgently evaluate for hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), adult-onset Still's disease (AOSD), catastrophic antiphospholipid syndrome, and septic shock.
Initial Diagnostic Approach
Critical Laboratory Evaluation
When ferritin is elevated, the TSAT-guided pathway is essential 1:
- Ferritin >5000 ng/mL with cytopenias in the context of fever raises immediate concern for HLH/MAS 2
- Ferritin >10,000 ng/mL is highly suggestive of HLH, though this threshold was derived from pediatric data 1
- TSAT <20% indicates absolute or functional iron deficiency rather than iron overload 3
- TSAT >40-45% suggests true iron overload and requires different management 4
Immediate Laboratory Panel
Obtain the following urgently 2, 5, 6:
- Complete blood count with differential (looking for cytopenias - all three cell lines dropping)
- Serum ferritin and transferrin saturation
- Liver enzymes (AST, ALT, bilirubin) - grade ≥3 elevation supports HLH/MAS
- Coagulation profile (fibrinogen, PT/PTT, D-dimer)
- Triglycerides and LDH
- Creatinine and urine output monitoring
- ESR and CRP
- Blood and urine cultures
Distinguishing the Four Life-Threatening Hyperferritinemic Syndromes
1. HLH/Macrophage Activation Syndrome
Calculate the H-score immediately 6, 7. HLH/MAS is diagnosed when:
- Rapidly rising ferritin >5000 ng/mL with cytopenias
- Persistent non-remitting fever
- Hepatosplenomegaly
- Hypofibrinogenemia and coagulopathy
- Elevated triglycerides (>265 mg/dL)
- Hemophagocytosis on bone marrow (confirms but absence doesn't exclude)
Critical pitfall: In adults, H-score ≥169 reaches 82-95% sensitivity and 60-94% specificity 1. In children, lower ferritin thresholds (500-1000 μg/L) may be significant 6.
2. Adult-Onset Still's Disease
- Quotidian fever pattern (daily spiking fever with return to normal)
- Salmon-pink evanescent rash
- Polyarthralgia/polyarthritis (especially wrists, knees, ankles)
- Sore throat
- Ferritin typically 4000-30,000 ng/mL, occasionally up to 250,000 ng/mL
- Glycosylated ferritin <20% is highly specific (93% specificity when combined with 5-fold ferritin elevation) 8
- Leukocytosis with neutrophilia (not cytopenias)
- Normal or elevated platelet count (distinguishes from HLH/MAS)
3. Septic Shock
Rule out infection aggressively 11, 12:
- Blood, urine, and respiratory cultures
- Procalcitonin
- Imaging for source (chest X-ray, abdominal CT if indicated)
- Fever typically lacks diurnal variation
- History of immunosuppression, recent procedures, or endemic exposures
4. Catastrophic Antiphospholipid Syndrome
Less common but consider if 12:
- Multi-organ thrombosis
- History of pregnancy morbidity or thrombosis
- Positive antiphospholipid antibodies
Treatment Algorithm
For Suspected HLH/MAS (H-score ≥169 or clinical suspicion)
Initiate treatment immediately - high mortality if delayed 2, 7:
- First-line: Anti-IL-6 therapy (tocilizumab) + high-dose corticosteroids (methylprednisolone 1-2 mg/kg/day)
- If refractory to tocilizumab: Add anakinra (IL-1 receptor antagonist) - particularly effective for late-onset or tocilizumab-refractory cases 2, 7
- Last resort for refractory cases: Etoposide (per HLH-2004 protocol), though avoid if possible due to T-cell toxicity 2, 7
In CAR T-cell associated HLH/MAS: Diagnose if peak ferritin >10,000 ng/mL plus ≥2 grade 3 organ toxicities (liver, kidney, lung) or hemophagocytosis 7
For AOSD with Impending MAS
Treat both conditions simultaneously 13, 9:
- High-dose glucocorticoids (≥1 mg/kg/day prednisone equivalent in adults, 2 mg/kg/day in children)
- IL-1 inhibitor (anakinra preferred) or IL-6 inhibitor (tocilizumab) 9
- Anakinra is specifically preferred when MAS is suspected (use high-dose: >100 mg twice daily in adults, >4 mg/kg/day in children) 9
- Progressive glucocorticoid tapering once fever resolves and joint count decreases by 50%
For AOSD Without MAS Features
Follow the 2024 EULAR/PRES algorithm 9:
High disease activity (high spiking fever, widespread polyarthritis, pericarditis, elevated LFTs):
- High-dose glucocorticoids (IV then oral)
- IL-1 inhibitor or IL-6 inhibitor
- Target: clinically inactive disease (CID) on low-dose GC at 3 months
Low/intermediate disease activity:
- IL-1 or IL-6 inhibitor with low-dose glucocorticoids
- Target: CID off GC at 6 months
If targets not met: Rotate between IL-1 and IL-6 inhibitors while continuing GC taper
Key Diagnostic Pitfalls to Avoid
Don't assume hyperferritinemia equals iron overload: Most cases with elevated ferritin do not have iron overload 1, 14. TSAT <20% excludes iron overload.
Don't wait for hemophagocytosis on bone marrow: Absence doesn't exclude HLH/MAS 5. Treat based on H-score and clinical picture.
Don't delay treatment for complete diagnostic workup: HLH/MAS has high mortality if treatment is delayed 2. Start immunosuppression while completing evaluation.
Don't miss the fever pattern: Quotidian fever (daily spikes returning to normal) suggests AOSD, while non-remitting fever suggests HLH/MAS 5, 9.
Don't overlook falling ESR with rising ferritin: This paradoxical pattern strongly suggests HLH/MAS rather than other inflammatory conditions 5.
Don't forget to rule out malignancy: Check LDH disproportionately high compared to ferritin, normal WBC/platelet counts despite high ESR - these suggest leukemia/lymphoma 5.
Monitoring and Follow-up
- Serial ferritin, CBC, liver enzymes, and coagulation studies every 24-48 hours initially
- H-score recalculation if clinical deterioration
- Glycosylated ferritin if AOSD suspected (order early as results take time)
- Bone marrow aspirate if diagnosis remains unclear after 48-72 hours